Ameriprise’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-357
Closed -$29K 4493
2014
Q3
$29K Sell
357
-2
-0.6% -$171 ﹤0.01% 4285
2014
Q2
$32K Buy
359
+268
+295% +$23.8K ﹤0.01% 4105
2014
Q1
$11K Sell
91
-2
-2% -$194 ﹤0.01% 4499
2013
Q4
$7K Sell
93
-71
-43% -$2.89K ﹤0.01% 4527
2013
Q3
$9K Hold
164
﹤0.01% 4984
2013
Q2
$12K Buy
+164
New +$9.47K ﹤0.01% 4656

Other funds holding ALIM

Ameriprise's ALIM Position: Q4 2014 in Review

Ameriprise sold out of Alimera Sciences (ALIM) in Q4 2014, closing a stake of 357 shares — an estimated $29K sold.

Ameriprise first reported a position in ALIM in Q2 2013 and held it in 6 quarters. The position peaked at $32K in Q2 2014. 67 funds tracked by Wall St. Rank hold ALIM as of Q4 2014.

  • Ameriprise reported no remaining Alimera Sciences position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 357 Alimera Sciences shares in Q4 2014, an estimated $29K.
  • Ameriprise first reported a position in Alimera Sciences in Q2 2013 and held it in 6 quarters.
  • Ameriprise's Alimera Sciences position peaked at $32K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.